menopause and microdosing glp 1 Semaglutide Menopause: Does It Work? What to know when using

The characteristic changes of GLP-1 face include 4,5 : Facial volume loss, particularly in the midface Periocular hollowing and periorbital volume depletion Dermal thinning with loss of collagen and elastin fibers Decreased skin elasticity leading to redundant skin folds Accelerated appearance of aging As a result of these facial changes, GLP-1 agonist medications can result in an older, haggard and tired looking appearance

In case of severe symptoms, consult a doctor

Additional concerns stem from potentially dangerous additives, harmful contaminants, or incorrect labelling

This is because cellulite is more than just fat

[DOI] [PMC free article] [PubMed] [Google Scholar] 219.Karras S.N., Rapti E., Koufakis T., Kyriazou A., Goulis D.G., Kotsa K

However, while GLP-1 receptor agonists may eventually play a role perhaps even a significant one in the specialty, more information is needed to more concretely determine its benefits